-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly develop viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious diseases globally through the discovery and development of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
News & Media
Press releases & statements
Dec 16, 2022
Statement
COVID-19
Global health
Jul 7, 2022
Statement
COVID-19
Global health
Jul 1, 2022
Statement
COVID-19
Global health
Jun 28, 2022
Statement
COVID-19
Global health
Jun 23, 2022
Statement
COVID-19
Global health
May 31, 2022
Statement
COVID-19
Global health
May 26, 2022
Statement
COVID-19
Global health
May 25, 2022
Statement
COVID-19
Global health
Showper page